Leonardo Rojas

924 total citations
40 papers, 268 citations indexed

About

Leonardo Rojas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Leonardo Rojas has authored 40 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Leonardo Rojas's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Leonardo Rojas is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Diagnosis and Treatment (11 papers). Leonardo Rojas collaborates with scholars based in Colombia, Mexico and Spain. Leonardo Rojas's co-authors include Óscar Arrieta, Andrés F. Cardona, Alejandro Ruíz-Patiño, Luis Corrales, Claudio Martín, Rafael Rosell, Carlos Vargas, Hernán Carranza, Zyanya Lucía Zatarain-Barrón and Jorge Otero and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Leonardo Rojas

32 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonardo Rojas Colombia	10	151	147	72	61	33	40	268
Víctor Rodríguez-Freixinós Spain	11	129 0.9×	194 1.3×	84 1.2×	60 1.0×	61 1.8×	27	319
Alessandra Ferro Italy	11	174 1.2×	183 1.2×	79 1.1×	76 1.2×	24 0.7×	37	315
Weiheng Hu China	8	154 1.0×	268 1.8×	59 0.8×	36 0.6×	59 1.8×	35	334
Linpeng Zheng China	10	150 1.0×	207 1.4×	77 1.1×	71 1.2×	32 1.0×	17	304
Guangming Tian China	10	172 1.1×	291 2.0×	63 0.9×	43 0.7×	60 1.8×	33	357
Yuto Yasuda Japan	10	172 1.1×	221 1.5×	121 1.7×	62 1.0×	19 0.6×	35	346
Brice Chanez France	11	74 0.5×	139 0.9×	51 0.7×	35 0.6×	41 1.2×	31	258
Xiangjuan Ma China	9	153 1.0×	274 1.9×	62 0.9×	33 0.5×	69 2.1×	34	335
Kammei Rai Japan	8	138 0.9×	104 0.7×	144 2.0×	112 1.8×	19 0.6×	34	333
Manoj Shah India	11	112 0.7×	163 1.1×	121 1.7×	65 1.1×	42 1.3×	29	346

Countries citing papers authored by Leonardo Rojas

Since Specialization

Citations

This map shows the geographic impact of Leonardo Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonardo Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonardo Rojas more than expected).

Fields of papers citing papers by Leonardo Rojas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonardo Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonardo Rojas. The network helps show where Leonardo Rojas may publish in the future.

Co-authorship network of co-authors of Leonardo Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Leonardo Rojas. A scholar is included among the top collaborators of Leonardo Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonardo Rojas. Leonardo Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruíz-Patiño, Alejandro, July Rodríguez, Darwin A. Moreno‐Pérez, et al.. (2024). Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO Global Oncology. 10(10). e2300011–e2300011. 2 indexed citations

Viola, Lucía, et al.. (2023). Recomendaciones para el diagnóstico, seguimiento y tratamiento cáncer del pulmón de células no pequeñas temprano en Colombia. 45(4). 767–804.

Rojas, Leonardo, et al.. (2023). Avances en el diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas sin alteraciones genómicas. 45(4). 687–698.

Arrieta, Óscar, Andrés F. Cardona, Vladmir Cláudio Cordeiro de Lima, et al.. (2023). P2.10-13 Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice. Journal of Thoracic Oncology. 18(11). S357–S358.

Rojas, Leonardo, et al.. (2023). Futuro diagnóstico y terapéutico del cáncer de pulmón de células no pequeñas con alteraciones genómicas. 45(4). 699–708.

García-Robledo, Juan Esteban, Rafael Rosell, Alejandro Ruíz-Patiño, et al.. (2022). KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block. Therapeutic Advances in Respiratory Disease. 16. 2663645392–2663645392. 10 indexed citations

Ordóñez‐Reyes, Camila, Juan Esteban García-Robledo, Alejandro Ruíz-Patiño, et al.. (2022). Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question. Pharmaceutics. 14(6). 1243–1243. 26 indexed citations

Raez, Luis E., Óscar Arrieta, Luis Corrales, et al.. (2022). Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP). Frontiers in Oncology. 12. 904800–904800. 8 indexed citations

Zatarain-Barrón, Zyanya Lucía, Andrés F. Cardona, Leonardo Rojas, et al.. (2021). Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort. Oncology. 99(8). 539–546. 3 indexed citations

10.

Rolfo, Christian, Andrés F. Cardona, Alejandro Ruíz-Patiño, et al.. (2020). Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer. Journal of Thoracic Oncology. 15(11). 1767–1772. 10 indexed citations

11.

Cardona, Andrés F., Alejandro Ruíz-Patiño, Zyanya Lucía Zatarain-Barrón, et al.. (2019). Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib. PLoS ONE. 14(6). e0217340–e0217340. 18 indexed citations

12.

Martín, Claudio, Andrés F. Cardona, Zyanya Lucía Zatarain-Barrón, et al.. (2018). Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices. Oncology. 94(5). 297–305. 7 indexed citations

13.

Corrales, Luis, Óscar Arrieta, Luís Más, et al.. (2017). An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung Cancer. 113. 30–36. 25 indexed citations

14.

Wills, Beatriz, Andrés F. Cardona, Leonardo Rojas, et al.. (2017). Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab. Anticancer Research. 37(11). 6429–6436. 10 indexed citations

15.

Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2016). O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP). Journal of Thoracic Oncology. 11(10). S168–S168. 1 indexed citations

16.

Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). PD2.04 (also presented as P1.42): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S177–S178. 1 indexed citations

17.

Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P1.42 (also presented as PD2.04): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S208–S209. 1 indexed citations

18.

Cardona, Andrés F., Leonardo Rojas, Beatriz Wills, et al.. (2016). Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression. PLoS ONE. 11(5). e0154293–e0154293. 9 indexed citations

19.

Corredor, Javier, et al.. (2013). La Frontera Digital: Efectos Psicológicos de Internet en la Región de la Orinoquía.. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 6(2). 55–68. 1 indexed citations

20.

Arias, Fernando, Jorge Otero, Hernán Carranza, et al.. (2012). Morbilidad y mortalidad en una serie de pacientes con neoplasias del peritoneo, tratados con citorreducción peritoneal más quimioterapia hipertérmica intraperitoneal en el Hospital Universitario de la Fundación Santa Fe de Bogotá (ONCOLGroup - estudio ATIA). Revista de Gastroenterología de México. 77(2). 66–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact